new discovery targets in the nuclear receptor family

Orphagen has unique insight into additional, largely unexplored, NR targets based on its exploratory research.

These include:

• Potent antagonists to an orphan receptor critical for CNS and retinal development
• Assay expertise for orphan targets with strong validation in autoimmunity, hematology, and oncology